| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |